Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis

Post time 2024-4-18 08:16:58

journal：JAMA

Authors：Tracey G. Simon; Robert M. Wilechansky; Stefania Stoyanova; Alessandra Grossman; Laura E. Dichtel; Georg M. Lauer; Karen K. Miller; Yujin Hoshida; Kathleen E. Corey; Rohit Loomba; Raymond T. Chung; Andrew T. Chan

Published date：2024-3-19

DOI：10.1001/jama.2024.1215

PDF link：https://jamanetwork.com/journals ... 710362787.88302.pdf

Article link：http://dx.doi.org/10.1001/jama.2024.1215

Article Source：American Medical Association (AMA)。

Remark：

Post time 2024-4-18 08:16:59

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[JAMA] Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis Copy